Total Payments
$8,474
2024 Payments
$1,176
Companies
14
Transactions
420
Medicare Patients
129
Medicare Billing
$16,456
Payment Breakdown by Category
Food & Beverage$8,367 (98.7%)
Education$106.83 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,367 | 412 | 98.7% |
| Education | $106.83 | 8 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,634 | 71 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,576 | 79 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,547 | 77 | $0 (2024) |
| ITI, Inc. | $809.41 | 44 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $623.63 | 36 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $516.39 | 23 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $461.21 | 23 | $0 (2024) |
| Allergan Inc. | $370.41 | 21 | $0 (2018) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $274.94 | 16 | $0 (2024) |
| Lundbeck LLC | $238.11 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,176 | 47 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($274.94) |
| 2023 | $1,689 | 75 | ITI, Inc. ($381.51) |
| 2022 | $1,060 | 52 | ITI, Inc. ($427.90) |
| 2021 | $141.71 | 7 | Janssen Pharmaceuticals, Inc ($91.41) |
| 2020 | $181.85 | 5 | Alkermes, Inc. ($127.90) |
| 2019 | $609.23 | 34 | Otsuka America Pharmaceutical, Inc. ($242.01) |
| 2018 | $1,380 | 103 | Janssen Pharmaceuticals, Inc ($405.56) |
| 2017 | $2,237 | 97 | Otsuka America Pharmaceutical, Inc. ($539.06) |
All Payment Transactions
420 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: CNS | ||||||
| 09/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: Neuropsychiatry | ||||||
| 08/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $0.52 | General |
| Category: Neuropsychiatry | ||||||
| 08/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: PSYCHIATRY | ||||||
| 08/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Neuropsychiatry | ||||||
| 08/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Neuropsychiatry | ||||||
| 08/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: CNS | ||||||
| 07/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: PSYCHIATRY | ||||||
| 07/29/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Neurology | ||||||
| 07/26/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: Neuroscience | ||||||
| 07/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Neuroscience | ||||||
| 07/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: CNS | ||||||
| 06/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: PSYCHIATRY | ||||||
| 05/31/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: Neuroscience | ||||||
| 05/31/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: Neuroscience | ||||||
| 05/30/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $119.48 | General |
| Category: CNS | ||||||
| 05/20/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 49 | 114 | $11,268 | $6,852 |
| 2022 | 2 | 66 | 83 | $11,653 | $8,205 |
| 2021 | 1 | 14 | 15 | $2,104 | $1,399 |
Total Patients
129
Total Services
212
Medicare Billing
$16,456
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 88 | $9,291 | $5,574 | 60.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 26 | $1,977 | $1,278 | 64.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 37 | 38 | $6,956 | $4,908 | 70.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 45 | $4,698 | $3,298 | 70.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 15 | $2,104 | $1,399 | 66.5% |
About Dr. Gabrielle Cerda, M.D
Dr. Gabrielle Cerda, M.D is a Psychiatry healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407887748.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gabrielle Cerda, M.D has received a total of $8,474 in payments from pharmaceutical and medical device companies, with $1,176 received in 2024. These payments were reported across 420 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($8,367).
As a Medicare-enrolled provider, Cerda has provided services to 129 Medicare beneficiaries, totaling 212 services with total Medicare billing of $16,456. Data is available for 3 years (2021–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location San Diego, CA
- Active Since 07/05/2006
- Last Updated 12/04/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1407887748
Products in Payments
- INVEGA SUSTENNA (Drug) $1,376
- CAPLYTA (Drug) $1,084
- REXULTI (Drug) $1,036
- ARISTADA (Drug) $725.84
- INGREZZA (Drug) $623.63
- ABILIFY MAINTENA (Drug) $591.87
- VRAYLAR (Drug) $587.52
- Aristada 441 mg (Drug) $523.19
- LATUDA (Drug) $516.39
- UZEDY (Drug) $238.83
- AUSTEDO (Drug) $222.38
- PERSERIS (Drug) $154.57
- VIVITROL (Drug) $138.15
- Vivitrol 380 mg (Drug) $128.60
- TRINTELLIX (Drug) $120.05
- SPRAVATO (Drug) $98.92
- LYBALVI (Drug) $94.53
- ABILIFY ASIMTUFII (Drug) $66.57
- INVEGA TRINZA (Drug) $42.11
- INVEGA (Drug) $29.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Diego
Dr. Jonathan Meyer, M.d, M.D
Psychiatry — Payments: $2.0M
Psychiatry $2.0M
Dr. Sanjai Rao, M.d, M.D
Psychiatry — Payments: $633,149
Psychiatry $633,149
Dr. Murray Stein, M.d., M.p.h, M.D., M.P.H
Psychiatry — Payments: $115,110
Psychiatry $115,110
Dr. Mukesh Sanghadia, M.d., Mrcpsych(Uk), M.D., MRCPSYCH(UK)
Psychiatry — Payments: $82,626
Psychiatry $82,626
Dr. Neil Richtand, M.d, M.D
Psychiatry — Payments: $76,458
Psychiatry $76,458
Clark Smith, Md, MD
Psychiatry — Payments: $72,261
Psychiatry $72,261